New bladder cancer combo aims to save bladders
NCT ID NCT07445308
First seen Mar 11, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This early-stage trial tests a new drug called SPGL008, alone or with an existing therapy (BCG), in 120 people with high-risk bladder cancer that hasn't invaded muscle. The goal is to find a safe dose and see if it can control the cancer, potentially helping patients avoid bladder removal surgery. Participants must be unable or unwilling to have their bladder removed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NMIBC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.